BCYC FY 2021 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+12.6% YoY

Gross Profit

$12M100.0% margin

Operating Income

-$66M-561.0% margin

Net Income

-$67M-571.2% margin

EPS (Diluted)

$-2.67

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$480M

Total Liabilities

$134M

Stockholders' Equity

$346M

Cash & Equivalents

$439M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$10M	+12.6%
Gross Profit	$12M	-$23M	+151.4%
Operating Income	-$66M	-$52M	-26.3%
Net Income	-$67M	-$51M	-31.0%